Neuropsychiatric damage in southern Chinese patients with systemic lupus erythematosus

Medicine

Volumn 85, Issue 4, 2006, Pages 221-228

  Mok, Chi Chiu ^a   To, Chi Hung ^a   Mak, Anselm ^a  

^a TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PREDNISOLONE;

ACUTE CONFUSION; ADULT; ANXIETY DISORDER; ARTICLE; ASEPTIC MENINGITIS; AUTONOMIC NEUROPATHY; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHINESE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; CRANIAL NEUROPATHY; DEMOGRAPHY; DEMYELINATING DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG MEGADOSE; DRUG PULSE THERAPY; EVALUATION; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HEADACHE; HIGH RISK PATIENT; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MONONEUROPATHY; MOOD DISORDER; MORTALITY; MOTOR DYSFUNCTION; MULTIPLE REGRESSION; MYASTHENIA GRAVIS; NEUROPATHY; NEUROPSYCHIATRY; NOMENCLATURE; ONSET AGE; PERIPHERAL NEUROPATHY; POLYNEUROPATHY; PREDICTION; PREDICTOR VARIABLE; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PSYCHOSIS; REGRESSION ANALYSIS; RHEUMATOLOGY; RISK FACTOR; RISK REDUCTION; SCORING SYSTEM; SEIZURE; SPINAL CORD DISEASE; STATISTICAL MODEL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CENTRAL NERVOUS SYSTEM DISEASES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; PREVALENCE;

EID: 33746303549     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.md.0000231955.08350.1b     Document Type: Article

References (29)

1. Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, Del Porto F, Finamore L, Pascucci S, Gasparini M, Lagana B, Caccavo D, Ferri GM, Amoroso A, Francia A. Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology. 2003;61:108-110.
2. Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsanoja R, Auvinen A. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001;45:419-423.
3. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001;57:496-500.
4. Alarcon GS, McGwin G Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, Bastian HM, Friedman AW, Reveille JD; LUMINA Study Group. Lupus in minority populations, nature versus nurture. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual. Arthritis Rheum. 2001;44:2797-2806.
5. Alarcon GS, Roseman JM, McGwin G Jr, Uribe A, Bastian HM, Fessler BJ, Baethge BA, Friedman AW, Reveille JD; LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage. Rheumatology (Oxf). 2004;43:202-205.
6. American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599-608.
7. Appenzeller S, Cendes F, Costallat LT. Epileptic seizures in systemic lupus erythematosus. Neurology. 2004;63:1808-1812.
8. Blanco FJ, Gomez-Reino JJ, de la Mata J, Corrales A, Rodriguez-Valverde V, Rosas JC, Gomez de la Camara A, Pascual E. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus. 1998;7:159-163.
9. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, Valdez CR, Escalante A, del Rincon I, Gronseth G, Rhine CB, Padilla P, McGlasson D. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology. 2002;58:1214-1220.
10. D'Cruz DP, Mellor-Pita S, Joven B, Sanna G, Allanson J, Taylor J, Khamashta MA, Hughes GR. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol. 2004;31:280-285.
11. Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc. 1997;3:377-386.
12. Ginzler EM, Diamond HS, Weiner M, Schlesinger M, Fries JF, Wasner C, Medsger TA Jr, Ziegler G, Klippel JH, Hadler NM, Albert DA, Hess EV, Spencer-Green G, Grayzel A, Worth D, Hahn BH, Barnett EV. A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum. 1982;25:601-611.
13. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D, Kalunian K, Liang MH, Maddison P, Nived O. Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol. 1994;21:1468-1471.
14. Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Fortin P, Ginzler E, Gordon C, Hanly JG, Isenberg DA, Petri M, Nived O, Snaith M, Sturfelt G. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for systemic lupus erythematosus international comparison. J Rheumatol. 2000;27:373-376.
15. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol. 2004;31:2156-2162.
16. Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol. 2005;32:1459-1466.
17. Jonsen A, Bengtsson AA, Nived O, Ryberg B, Sturfelt G. Outcome of neuropsychiatric systemic lupus erythematosus within a defined Swedish population: increased morbidity but low mortality. Rheumatology (Oxf). 2002;41:1308-1312.
18. Kovacs B, Lafferty TL, Brent LH, DeHoratius RJ. Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature. Ann Rheum Dis. 2000;59:120-124.
19. Lee P, Urowitz MB, Bookman AA, Koehler BE, Smythe HA, Gordon DA, Ogryzlo MA. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med. 1977;46:1-32.
20. Leritz E, Brandt J, Minor M, Reis-Jensen F, Petri M. Neuropsychological functioning and its relationship to antiphospholipid antibodies in patients with systemic lupus erythematosus. J Clin Exp Neuropsychol. 2002;24:527-533.
21. McLaurin EY, Holliday SL, Williams P, Brey RL. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. Neurology. 2005;64:297-303.
22. Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxf). 2004;43:1555-1560.
23. Mikdashi J, Krumholz A, Handwerger B. Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus. Neurology. 2005;64:2102-2107.
24. Mok CC, Lau CS, Wong RWS. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol. 2001;28:766-771.
25. Mok CC, Mak A, Chu WP, To CH, Wong SN. Long-term survival of southern Chinese patients with systemic lupus erythematosus: a prospective study of all age-groups. Medicine (Baltimore). 2005;84:218-224.
26. Rahman P, Gladman DD, Urowitz MB, Hallett D, Tam LS. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus. 2001;10:93-96.
27. Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, Mathieu A, Hughes GR. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol. 2003;30:985-992.
28. Sibbitt WL Jr, Brandt JR, Johnson CR, Maldonado ME, Patel SR, Ford CC, Bankhurst AD, Brooks WM. The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol. 2002;29:1536-1542.
29. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277.